2014
DOI: 10.5650/jos.ess13226
|View full text |Cite
|
Sign up to set email alerts
|

The Proportion of Nervonic Acid in Serum Lipids is Associated with Serum Plasmalogen Levels and Metabolic Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
40
1
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 59 publications
(50 citation statements)
references
References 35 publications
6
40
1
3
Order By: Relevance
“…Thus, it seems the plasmalogen status does not indicate any defective function in our rat model, while plasmalogens are crucial, for instance, for Schwann cell development and differentiation [59] or as neuroprotective against apoptosis [60], although the role of the alkenyl species remains poorly documented and requires detailed study. Yamazaki showed a structural evolution in plasmenylcholine and plasmenylethanolamine in metabolic syndrome [61]. Kaddurah-Daouk also demonstrated a modulation in the fatty aldehyde structure during the psychotic episode of schizophrenia [62].…”
Section: Discussionmentioning
confidence: 97%
“…Thus, it seems the plasmalogen status does not indicate any defective function in our rat model, while plasmalogens are crucial, for instance, for Schwann cell development and differentiation [59] or as neuroprotective against apoptosis [60], although the role of the alkenyl species remains poorly documented and requires detailed study. Yamazaki showed a structural evolution in plasmenylcholine and plasmenylethanolamine in metabolic syndrome [61]. Kaddurah-Daouk also demonstrated a modulation in the fatty aldehyde structure during the psychotic episode of schizophrenia [62].…”
Section: Discussionmentioning
confidence: 97%
“…We show decreased nervonic acid, increased DGLA, and increased palmitoleic acid incorporation into PPLs of overweight and obese individuals. Previously, decreased nervonic acid and increased palmitoleic acid in PPLs has been documented in metabolic syndrome (MetS) [6, 24]. Compared to lean participants, obese individuals had significantly increased WC, leptin, C-peptide, MCP-1, and TNF-α, and also significantly decreased adiponectin.…”
Section: Discussionmentioning
confidence: 99%
“…Although physiological function of circulating plasmalogen is not well elucidated, plasma concentration of plasmalogen is reported to be reduced in Alzheimer disease 16) , metabolic syndrome 17) and inflammatory bowel disease 18) . These reports imply that systemic or local inflammation is deeply involved in the metabolism of plasmalogens, and that plasmalogen may play a protective role against persistent inflammation.…”
Section: Plasma Concentration Of Plasmalogenmentioning
confidence: 99%